Neumora Therapeutics 2024年第四季度GAAP每股收益$(0.37),优于预期的$(0.45),现金余额为3.076亿美元

财报速递
Mar 03, 2025
Neumora Therapeutics(LENZ) 2024年第四季度GAAP每股收益$(0.37),优于预期的$(0.45),现金余额为3.076亿美元

以上内容来自Benzinga Earnings专栏,原文如下:

Neumora Therapeutics Q4 2024 GAAP EPS $(0.37) Beats $(0.45) Estimate, Cash Balance Of $307.6M

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10